Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA02000038 12,13 EpOME cPLA2i 1.0 BCD110605C28 0.05 pmol/ml medium
LMFA02000038 12,13 EpOME cPLA2i 1.0 BCD110605C30 0.061 pmol/ml medium
LMFA02000038 12,13 EpOME cPLA2i 1.0 BCD110605C29 0.062 pmol/ml medium
LMFA02000038 12,13 EpOME cPLA2i 20.0 BCD110605C64 0.066 pmol/ml medium
LMFA02000038 12,13 EpOME cPLA2i 20.0 BCD110605C66 0.061 pmol/ml medium
LMFA02000038 12,13 EpOME cPLA2i 20.0 BCD110605C65 0.057 pmol/ml medium
LMFA02000038 12,13 EpOME PLDi 1.0 BCD110605C16 0.057 pmol/ml medium
LMFA02000038 12,13 EpOME PLDi 1.0 BCD110605C18 0.045 pmol/ml medium
LMFA02000038 12,13 EpOME PLDi 1.0 BCD110605C17 0.052 pmol/ml medium
LMFA02000038 12,13 EpOME PLDi 20.0 BCD110605C54 0.046 pmol/ml medium
LMFA02000038 12,13 EpOME PLDi 20.0 BCD110605C53 0.054 pmol/ml medium
LMFA02000038 12,13 EpOME PLDi 20.0 BCD110605C52 0.064 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+cPLA2i 1.0 BCD110605C32 0.037 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+cPLA2i 1.0 BCD110605C31 0.05 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+cPLA2i 1.0 BCD110605C33 0.052 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+cPLA2i 20.0 BCD110605C68 0.021 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+cPLA2i 20.0 BCD110605C69 0.026 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+cPLA2i 20.0 BCD110605C67 0.023 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+PLDi 1.0 BCD110605C19 0.045 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+PLDi 1.0 BCD110605C20 0.05 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+PLDi 1.0 BCD110605C21 0.041 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+PLDi 20.0 BCD110605C57 0.038 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+PLDi 20.0 BCD110605C55 0.024 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+PLDi 20.0 BCD110605C56 0.025 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+ATP+cPLA2i 1.0 BCD110605C38 0.034 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+ATP+cPLA2i 1.0 BCD110605C37 0.062 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+ATP+cPLA2i 1.0 BCD110605C39 0.062 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+ATP+cPLA2i 20.0 BCD110605C74 0.015 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+ATP+cPLA2i 20.0 BCD110605C73 0.013 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+ATP+cPLA2i 20.0 BCD110605C75 0.003 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+ATP+PLDi 1.0 BCD110605C26 0.064 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+ATP+PLDi 1.0 BCD110605C27 0.048 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+ATP+PLDi 1.0 BCD110605C25 0.059 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+ATP+PLDi 20.0 BCD110605C62 0.004 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+ATP+PLDi 20.0 BCD110605C63 0.01 pmol/ml medium
LMFA02000038 12,13 EpOME KDO+ATP+PLDi 20.0 BCD110605C61 0.015 pmol/ml medium
LMFA02000038 12,13 EpOME KDO + ATP 1.0 BCD110605C15 0.052 pmol/ml medium
LMFA02000038 12,13 EpOME KDO + ATP 1.0 BCD110605C13 0.044 pmol/ml medium
LMFA02000038 12,13 EpOME KDO + ATP 1.0 BCD110605C14 0.037 pmol/ml medium
LMFA02000038 12,13 EpOME KDO + ATP 20.0 BCD110605C51 0.01 pmol/ml medium
LMFA02000038 12,13 EpOME KDO + ATP 20.0 BCD110605C49 0.017 pmol/ml medium
LMFA02000038 12,13 EpOME KDO + ATP 20.0 BCD110605C50 0.012 pmol/ml medium
LMFA02000038 12,13 EpOME KDO 1.0 BCD110605C09 0.07 pmol/ml medium
LMFA02000038 12,13 EpOME KDO 1.0 BCD110605C08 0.051 pmol/ml medium
LMFA02000038 12,13 EpOME KDO 1.0 BCD110605C07 0.056 pmol/ml medium
LMFA02000038 12,13 EpOME KDO 20.0 BCD110605C43 0.058 pmol/ml medium
LMFA02000038 12,13 EpOME KDO 20.0 BCD110605C44 0.033 pmol/ml medium
LMFA02000038 12,13 EpOME KDO 20.0 BCD110605C45 0.058 pmol/ml medium
LMFA02000038 12,13 EpOME C 0.0 BCD110605C03 0.032 pmol/ml medium
LMFA02000038 12,13 EpOME C 0.0 BCD110605C02 0.08 pmol/ml medium